InvestorsHub Logo
Followers 13
Posts 2065
Boards Moderated 0
Alias Born 05/15/2009

Re: None

Monday, 02/28/2011 8:11:40 AM

Monday, February 28, 2011 8:11:40 AM

Post# of 358

of 40870


DEPO

Depomed has added a news release to its Investor Relations website.
Title: Depomed Announces Receipt of a $48 million Milestone Payment for the Approval of GRALISE(TM)

Date(s): 28-Feb-2011 8:00 AM

For a complete listing of our news releases, please click here



Menlo Park, Calif., February 28, 2011 - Depomed, Inc. (NASDAQ: DEPO) today announced that it has received a $48 million milestone payment from Abbott Products, Inc., for the U.S. Food and Drug Administration's approval of GRALISE(TM) (gabapentin) Tablets for once-daily treatment of post-herpetic neuralgia (PHN), which is pain following healing of the rash associated with shingles.

The early bird gets the worm................

But it's the second mouse that gets the cheese...........